SCHEMBL386559

SCHEMBL386559

CN(C)C(=O)CCCCc1ccccc1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 6/20 0.77
MAPT P10636 1/20 0.61
RXFP1 Q9HBX9 1/20 0.61
KDM4A O75164 1/20 0.59
KDM5A P29375 1/20 0.59
KDM4C Q9H3R0 1/20 0.59
PHF8 Q9UPP1 1/20 0.59
KDM2A Q9Y2K7 1/20 0.59
HDAC1 Q13547 2/20 0.55
HDAC2 Q92769 2/20 0.55
HDAC3 O15379 1/20 0.55
MAPK1 P28482 1/20 0.55
ADRA1A P35348 1/20 0.55
HDAC4 P56524 1/20 0.55
SLC6A3 Q01959 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
HDAC7 Q8WUI4 1/20 0.55
HDAC10 Q969S8 1/20 0.55
HDAC11 Q96DB2 1/20 0.55
HDAC8 Q9BY41 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16658770 0.98 ALOX5 (0.75) ALOX5MAPTRXFP1KDM4AKDM5A
SCHEMBL16658768 0.98 ALOX5 (0.75) ALOX5MAPTRXFP1KDM4AKDM5A
SCHEMBL16658769 0.98 ALOX5 (0.75) ALOX5MAPTRXFP1KDM4AKDM5A
SCHEMBL16658765 0.98 ALOX5 (0.75) ALOX5MAPTRXFP1KDM4AKDM5A
SCHEMBL16658767 0.98 ALOX5 (0.75) ALOX5MAPTRXFP1KDM4AKDM5A
SCHEMBL8493143 0.94 ALOX5 (0.69) ALOX5MAPTRXFP1KDM4AKDM5A
Hydrochloric Acid SCHEMBL27410606 0.93 ALOX5 (0.67) ALOX5MAPTRXFP1KDM4AKDM5A
SCHEMBL10695244 0.87 ALOX5 (1.00) ALOX5MAPTRXFP1KDM4AKDM5A
SCHEMBL3366949 0.86 KMT2A (0.70) ALOX5HDAC1HDAC2HDAC3MAPK1
SCHEMBL9662985 0.86 ALOX5 (0.97) ALOX5MAPTRXFP1KDM4AKDM5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107912040-B Pyrrolidine amide compounds as histone demethylase inhibitors 基因泰克公司 2021-04-06 CN disclosed
CN-107912040-A Pyrrolidine Amide Compounds As Histone Demethylase Inhibitors 基因泰克公司 2018-04-13 CN disclosed
US-8101650-B2 Method for treating a immunology-related disease DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-01-24 US disclosed
US-8067396-B2 Amino alcohol compounds or phosphonic acid derivatives thereof SANKYO COMPANY, LIMITED (JP) 2011-11-29 US disclosed
US-20100035842-A1 Amino alcohol compounds or phosphonic acid derivatives thereof SANKYO COMPANY, LIMITED (JP) 2010-02-11 US disclosed
US-20090326038-A1 Method for treating a immunology-related disease SANKYO COMPANY, LIMITED (JP) 2009-12-31 US disclosed
US-7638551-B2 Amino alcohol compounds or phosphonic acid derivatives thereof SANKYO COMPANY, LIMITED (JP) 2009-12-29 US disclosed
EP-1471054-B1 AMINO ALCOHOL DERIVATIVE OR PHOSPHONIC ACID DERIVATIVE AND MEDICINAL COMPOSITION CONTAINING THESE DAIICHI SANKYO CO LTD (JP) 2009-07-01 EP disclosed
US-20070142335-A1 Amino alcohol compounds or phosphonic acid derivatives thereof SANKYO COMPANY, LIMITED (JP) 2007-06-21 US disclosed
US-20070105933-A1 Amino alcohol compounds SANKYO COMPANY, LIMITED (JP) 2007-05-10 US disclosed
US-7199150-B2 Amino alcohol compounds SANKYO COMPANY, LIMITED (JP) 2007-04-03 US disclosed
US-20050043386-A1 Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these SANKYO COMPANY, LIMITED (JP) 2005-02-24 US disclosed
EP-1471054-A1 AMINO ALCOHOL DERIVATIVE OR PHOSPHONIC ACID DERIVATIVE AND MEDICINAL COMPOSITION CONTAINING THESE Sankyo Company, Limited (JP) 2004-10-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050043386-A1 Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these PHOSPHO1, CD4, FCGRT ALOX5 197/4885MAPT 3715/4885RXFP1 1194/4885
US-20090326038-A1 Method for treating a immunology-related disease C3AR1, HRH3, HRH2 ALOX5 251/4885MAPT 3338/4885RXFP1 725/4885
US-20070105933-A1 Amino alcohol compounds ADH1C, C9, SSB ALOX5 807/4885MAPT 2117/4885RXFP1 635/4885
US-20070142335-A1 Amino alcohol compounds or phosphonic acid derivatives thereof HRH3, C3AR1, HRH4 ALOX5 437/4885MAPT 1819/4885RXFP1 786/4885
US-20100035842-A1 Amino alcohol compounds or phosphonic acid derivatives thereof PHOSPHO1, ADH1C, ADH1A ALOX5 671/4885MAPT 3634/4885RXFP1 1552/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.